GLP1R and type 2 diabetes mellitus: We have recently shown that T2D decreases the number of CB-positive interneurons in the piriform cortex of the T2D rat and that this effect can be counteracted by the treatment with the glucagon-like peptide-1 receptor (GLP-1R) agonist exendin-4 (Ex-4) [24].